These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38512680)

  • 1. Measuring Antibody-Mediated Tau Fibril Uptake in Microglia by Flow Cytometry.
    Funk KE
    Methods Mol Biol; 2024; 2754():437-444. PubMed ID: 38512680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia.
    De Marco D; Taggenbrock R; Crespo R; Koudstaal W; Ramsburg E; Apetri A
    J Vis Exp; 2018 Nov; (141):. PubMed ID: 30474638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia: Friend and foe in tauopathy.
    Odfalk KF; Bieniek KF; Hopp SC
    Prog Neurobiol; 2022 Sep; 216():102306. PubMed ID: 35714860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Therapeutic Mechanisms of Tau Antibodies: Promoting Microglial Clearance Versus Blocking Neuronal Uptake.
    Funk KE; Mirbaha H; Jiang H; Holtzman DM; Diamond MI
    J Biol Chem; 2015 Aug; 290(35):21652-62. PubMed ID: 26126828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated clearance of tau in primary mouse microglial cultures requires Fcγ-receptor binding and functional lysosomes.
    Andersson CR; Falsig J; Stavenhagen JB; Christensen S; Kartberg F; Rosenqvist N; Finsen B; Pedersen JT
    Sci Rep; 2019 Mar; 9(1):4658. PubMed ID: 30874605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.
    Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT
    J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement.
    Lee SH; Le Pichon CE; Adolfsson O; Gafner V; Pihlgren M; Lin H; Solanoy H; Brendza R; Ngu H; Foreman O; Chan R; Ernst JA; DiCara D; Hotzel I; Srinivasan K; Hansen DV; Atwal J; Lu Y; Bumbaca D; Pfeifer A; Watts RJ; Muhs A; Scearce-Levie K; Ayalon G
    Cell Rep; 2016 Aug; 16(6):1690-1700. PubMed ID: 27475227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cofilin rods and aggregates concur with tau pathology and the development of Alzheimer's disease.
    Rahman T; Davies DS; Tannenberg RK; Fok S; Shepherd C; Dodd PR; Cullen KM; Goldsbury C
    J Alzheimers Dis; 2014; 42(4):1443-60. PubMed ID: 25024349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody.
    Luo W; Liu W; Hu X; Hanna M; Caravaca A; Paul SM
    Sci Rep; 2015 Jun; 5():11161. PubMed ID: 26057852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunctional microglia and tau pathology in Alzheimer's disease.
    Ayyubova G
    Rev Neurosci; 2023 Jun; 34(4):443-458. PubMed ID: 36302379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
    Sun XY; Li LJ; Dong QX; Zhu J; Huang YR; Hou SJ; Yu XL; Liu RT
    J Neuroinflammation; 2021 Jun; 18(1):131. PubMed ID: 34116706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
    Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
    Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
    Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
    Stancu IC; Cremers N; Vanrusselt H; Couturier J; Vanoosthuyse A; Kessels S; Lodder C; Brône B; Huaux F; Octave JN; Terwel D; Dewachter I
    Acta Neuropathol; 2019 Apr; 137(4):599-617. PubMed ID: 30721409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App
    Nuñez-Diaz C; Andersson E; Schultz N; Pocevičiūtė D; Hansson O; ; Nilsson KPR; Wennström M
    Alzheimers Res Ther; 2024 Jan; 16(1):4. PubMed ID: 38167557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease.
    Gerrits E; Brouwer N; Kooistra SM; Woodbury ME; Vermeiren Y; Lambourne M; Mulder J; Kummer M; Möller T; Biber K; Dunnen WFAD; De Deyn PP; Eggen BJL; Boddeke EWGM
    Acta Neuropathol; 2021 May; 141(5):681-696. PubMed ID: 33609158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internalization of tau antibody and pathological tau protein detected with a flow cytometry multiplexing approach.
    Shamir DB; Rosenqvist N; Rasool S; Pedersen JT; Sigurdsson EM
    Alzheimers Dement; 2016 Oct; 12(10):1098-1107. PubMed ID: 27016263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy.
    Chen X; Firulyova M; Manis M; Herz J; Smirnov I; Aladyeva E; Wang C; Bao X; Finn MB; Hu H; Shchukina I; Kim MW; Yuede CM; Kipnis J; Artyomov MN; Ulrich JD; Holtzman DM
    Nature; 2023 Mar; 615(7953):668-677. PubMed ID: 36890231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin-mediated Microglial Chemotaxis via G-Protein Coupled Purinergic Receptor in Alzheimer's Disease.
    Das R; Chinnathambi S
    Neuroscience; 2020 Nov; 448():325-336. PubMed ID: 32941933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.